Cronos Group

Aphria seeks EU GMP certification before closing deal for German distributor

Aphria, one of Canada’s largest medical cannabis companies, aims to obtain an essential European quality standard certification before closing its deal to buy a large distributor of pharmaceutical products in Germany. Aphria announced last week its intention to buy Densborn, Germany-based CC Pharma for 24.5 million euros ($28 million) in cash on closing and another […]

Read More

Canadian cannabis firm Aphria approved for NYSE listing

Aphria, one of Canada’s largest cannabis producers, has been approved to list its shares on the New York Stock Exchange. The firm will trade on the NYSE under the ticker symbol APHA starting Nov. 2. The Ontario-based company joins a growing list of Canadian cannabis firms turning to the top U.S. exchanges to tap the […]

Read More

Ahead of Canada’s big day, forecast for cannabis industry gets a boost

On the eve of Canada’s historic launch of its recreational marijuana program, the global cannabis industry appears poised for explosive growth thanks to the confluence of a host of market developments. “The well-capitalized cannabis industry has been evolving rapidly and looks to address a far larger (market) than we had originally forecast,” Wall Street analyst […]

Read More

Analyst says Cronos stock swings ‘overdone,’ calls deception allegations ‘unfounded’

Shares of Cronos Group were punished by investors this week after the Ontario-based licensed producer of cannabis was targeted by short-seller Andrew Left of Citron Research – but at least one analyst called the wild swing “overdone.” Citron’s report, issued Aug. 30, accused the Cronos management team of “deceiving the investing public” by not disclosing the […]

Read More

Australia sees significant increase in medical cannabis patient count

The streamlined processes for medical marijuana applications in Australia’s most populous state is starting to produce positive results, although patient access remains “appalling” across the country, according to at least one elected official.
Data shared with Marijuana Business Daily by the New South Wales health regulator shows that 322 applications for medical marijuana have been approved since the state made it easier for doctors to prescribe cannabis in March.

Read More

Ontario’s cannabis pivot could create massive retail opportunities

A week after it was reported that Ontario froze leasing efforts for its monopoly cannabis retail chain, Canada’s largest province appears to be on the verge of handing adult-use marijuana sales entirely to the private sector. The news, first reported by Cannabis Compliance Vice President Deepak Anand and then in The Globe and Mail, would reverse the […]

Read More